Neutropenia after penicillins: toxic or immune-mediated?

Area of Science:

• Immunology
• Pharmacology
• Hematology

Background:

• Neutropenia is a potential adverse effect of penicillin therapy.
• Understanding the immunologic mechanisms behind drug-induced neutropenia is crucial for patient safety.

Purpose of the Study:

• To investigate the incidence and potential immune pathogenesis of neutropenia associated with high-dose penicillin-G.
• To compare immune markers in patients who developed neutropenia versus those who did not.

Main Methods:

• Comparative study involving three groups: neutropenic patients, non-neutropenic patients on penicillin-G, and untreated controls.
• Measurement of anti-immunoglobulin G (IgG) antibodies and lymphocyte culture stimulation indices.
• Detection of antineutrophil antibodies using staphylococcal-slide assay, indirect immunofluorescence, and microcytotoxicity tests.

Main Results:

• Penicillin-G treatment, especially doses exceeding 200 million units, was frequently associated with neutropenia.
• Patients with penicillin-induced neutropenia exhibited elevated anti-IgG antibodies and lymphocyte stimulation indices compared to controls.
• Antineutrophil antibodies were detected in a subset of neutropenic patients via staphylococcal-slide assay.

Conclusions:

• High-dose penicillin-G frequently induces neutropenia, suggesting an immune-mediated pathogenesis.
• Penicillin-induced neutropenia appears to be a distinct entity from previously described types.
• Intravenous administration of substantial penicillin-G amounts consistently leads to drug sensitization.